Total returns on £1000
1Y
- 3M
- 6M
- 1Y
- 3Y
- 5Y
Fund/benchmark | Change | |
---|---|---|
Price | Syncona Limited (Ordinary Share) | -29.31% |
NAV | Syncona Limited (Ordinary Share) | -2.35% |
Morningstar's Benchmark | FTSE 250 TR GBP | -- |
- Transaction in Own Shares
- Autolus reports Q1 2024 Financial Results
- Freeline presents clinical data update
- Achilles reports Q1 2024 Financial Results
- Total Voting Rights
- Century Therapeutics to acquire Clade Therapeutics
- Achilles reports full year 2023 Financial Results
- Achilles provides clinical data update
- Autolus reports full year 2023 Financial Results
- Director Declaration
More ▼
Key statistics
On Wednesday, Syncona Limited (SYNC:LSE) closed at 112.20, 6.86% above its 52-week low of 105.00, set on Sep 28, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Shares outstanding | 650.85m |
---|---|
Market cap | 730.10m GBP |
Total assets | 1.22bn GBP |
Total expense ratio | 0.92% |
High | 112.80 |
Low | 111.80 |
Previous close | 112.20 |
Average volume | 897.26k |
---|---|
YTD Change | -9.08% |
Beta | 0.2931 |
Diluted NAV (est) | 188.20 |
Diluted NAV (last pub) | 188.20 |
Premium/Discount | -40.49% |
Net Gearing | 0.00% |
Data delayed at least 20 minutes, as of May 22 2024 16:48 BST.
More ▼